Greffex  
疫苗研发公司

Greffex is the innovative global leader in the delivery of accelerated pandemic and bio-terror vaccines using the world’s first universal platform, our GREVAX™ Vaccine Platform.

Our proven technology, the GREVAX™ Universal Platform, a fully-deleted, helper-independent adenoviral vector system, delivers unprecedented time-to-market, cost efficiency and safety.

Our vibrant pipeline of vaccines, transplantation and gene therapy products continue to create value for our people, partners and investors.